Qualified participants may receive compensation after every blood draw.
The total length of participation in this clinical trial is
approximately 2½ years (30 months).
Each participant has a 50% chance of receiving the investigational vaccine and a 50% chance of receiving a placebo—like flipping a coin.
Our team will contact you to verify your eligiblity and answer any questions you may have.